Greater R&D Funding Needed to Fight Diseases Affecting World’s Poor

Despite significant advancements in increasing distribution and development of vaccines against childhood killer diseases – including pneumococcal disease, rotavirus, and Haemophilus influenzae Type B – global efforts to reduce the burden of infection from neglected tropical diseases (NTDs) has greatly lagged, argues Sabin Vaccine Institute (Sabin) President Dr. Peter Hotez in an article for the June edition of Health Affairs.

Remember the last time you had the flu? The exhaustion, the fever, the aching body?

A key message in our Sustainable Immunization Financing (SIF) Program work is that countries need to reduce their dependencies by appropriating their routine immunization programs.

The 9th International Rotavirus Symposium brought together 365 participants from 65 countries from August 2-3, 2010 in Johannesburg, South Africa.

By Stephanie Bricking, Albert B. Sabin Archivist, University of Cincinnati

In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.

Pages